Stock Events

Stock Events

Regenerx Biopharmaceuticals 

$0
6
+$0+66.67% Today

Statistics

Day High
0.16
Day Low
0.16
52W High
0.16
52W Low
0
Volume
252
Avg. Volume
539
Mkt Cap
71,775
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
0
0.01
0.01
Expected EPS
0
Actual EPS
-0.0026

Financials

-2,242.86%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
154,000Revenue
-3.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGRX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Apple
AAPL
Mkt Cap3.76T
Apple Inc. competes in various technology sectors, overlapping with Gooi Global's interests in tech innovation and consumer electronics.
Alphabet
GOOGL
Mkt Cap3.58T
Alphabet Inc., through its various subsidiaries, competes directly in the digital services and technology solutions sectors.
Microsoft
MSFT
Mkt Cap2.78T
Microsoft Corporation offers software, hardware, and cloud solutions that directly compete with some of Gooi Global's tech offerings.
Amazon
AMZN
Mkt Cap2.25T
Amazon.com Inc. competes with Gooi Global in e-commerce, cloud computing, and digital streaming services.
ProShares S&P 500 Dynamic Buffer
FB
Mkt Cap0
Meta Platforms Inc., formerly Facebook, competes in the social media and digital advertising markets.
Intel
INTC
Mkt Cap252.96B
Intel Corporation provides semiconductor chips, competing with Gooi Global in the technology hardware sector.
International Business Machines
IBM
Mkt Cap232.88B
International Business Machines Corporation offers cloud and cognitive solutions that compete with Gooi Global's tech services.
Cisco Systems
CSCO
Mkt Cap312.22B
Cisco Systems, Inc. provides networking hardware, software, and telecommunications equipment that competes with Gooi Global's technology solutions.
Oracle
ORCL
Mkt Cap421B
Oracle Corporation offers database software and technology, cloud engineered systems, and enterprise software products that compete in the tech market.
HP
HPQ
Mkt Cap17.91B
HP Inc. competes in the personal computing and printing businesses, overlapping with Gooi Global's interests in consumer tech products.

About

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
Show more...
CEO
Dr. Allan L. Goldstein Ph.D.
Employees
2
Country
US
ISIN
US75886X3061

Listings

OTC Link
US
GOOI
OTC Link
US
RGRX

0 Comments

Share your thoughts

FAQ

What is Regenerx Biopharmaceuticals stock price today?▼
The current price of RGRX is $0 USD — it has increased by +66.67% in the past 24 hours. Watch Regenerx Biopharmaceuticals stock price performance more closely on the chart.
What is Regenerx Biopharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Regenerx Biopharmaceuticals stocks are traded under the ticker RGRX.
What is Regenerx Biopharmaceuticals market cap?▼
Today Regenerx Biopharmaceuticals has the market capitalization of 71,775
What were Regenerx Biopharmaceuticals earnings last quarter?▼
RGRX earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Regenerx Biopharmaceuticals revenue for the last year?▼
Regenerx Biopharmaceuticals revenue for the last year amounts to 154,000 USD.
What is Regenerx Biopharmaceuticals net income for the last year?▼
RGRX net income for the last year is -3.45M USD.
How many employees does Regenerx Biopharmaceuticals have?▼
As of April 06, 2026, the company has 2 employees.
In which sector is Regenerx Biopharmaceuticals located?▼
Regenerx Biopharmaceuticals operates in the Health Care sector.
When did Regenerx Biopharmaceuticals complete a stock split?▼
The last stock split for Regenerx Biopharmaceuticals was on October 18, 2023 with a ratio of 1:100.
Where is Regenerx Biopharmaceuticals headquartered?▼
Regenerx Biopharmaceuticals is headquartered in Rockville, US.